Influence of apolipoprotein E gene polymorphism on the risk for breast cancer

International Journal of Human Genetics

Volumn 8, Issue 3, 2008, Pages 277-282

  Surekha, D ^a   Vishnupriya, S ^a   Sailaja, K ^a   Nageswara Rao, D ^a   Raghunadharao, D ^b  

^a OSMANIA UNIVERSITY   (India)

^b NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Estrogen; Menopausal status; PCR RFLP; Progesterone; Receptor status

Indexed keywords

APOLIPOPROTEIN E; STEROID RECEPTOR;

ADULT; ADVANCED CANCER; ARTICLE; BODY MASS; BREAST CANCER; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; FAMILIAL INCIDENCE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREMENOPAUSE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 76049124720     PISSN: 09723757     EISSN: None     Source Type: Journal    
DOI: 10.1080/09723757.2008.11886040     Document Type: Article

References (29)

1. Alberts MJ, Graffagnino C, McClenny C, DeLong D, Striffmatter WJ, Saunders AM, Roses A 1995. Apo E Genotype and survival from intra cerebral hemorrhage. Lancet, 346: 545.
2. Corden EH, Saunders AM, Strittmatter WJ, Roses A 1993. Gene dose of Apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261: 921-923.
3. Das, HKJ Mehherson, GAP Brum, S K Kuralthanasis and JL Breslow 1985. Isolation, Charactersition and mapping to chromosome 19 of the human Apolipoprotein E Gene. J.Biol.Chem, 260: 6240-6247.
4. Davignon J, Gregg RE, Sing CF 1988. Apolipoprotein E polmorphism and atheresclerosis. Arteriosclerosis, 8: 1 - 21.
5. Emi Y, Kitamura K, Shikada Y, Takahashi I, and Tsutsui S 2002. Metastatic breast cancer with HER2/neupositive cells tends to have a morbid prognosis. Surgery, 131(Suppl 1): S217-S221.
6. Iihan Yaylim, Nilufer Bozkurt, Hulya Yilmaz, Turgay Isbir, Nilgun Isik, Soykan Arikan 2003. The apolipoprotein E E4 allele is not a risk factor for Turkish breast cancer patients. Cancer and Cytogenetics, 146: 86-87.
7. James E, Hixson and Daniel T.Vernier 1990. Restriction isotyping of human apolipoprotein E by Gene amplification and cleavage with HhaI.J.Lipid Res 31: 545-548.
8. Kervinen K, Sodervik H, Makela J, Lehtole J, Niemi M, Karailuoma MI, Kesaniemi VA 1996 . Is the development of the adenoma and carcinoma in proximal colon related to apportion E phenotype. Gastreentrol, 110: 1785-1790.
9. Leher S 1998. Possible relationship of the apolipoprotein E (APOE) e4 allele to prostrate cancer. Br I Can, 78(10): 1398.
10. Mahley RW 1988. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science, 240: 622-630.
11. Carron MO, Muir KW, Weir CJ, Dyker AG, Bone J, Nicoll JAR, Lees KR 1998.The Apolipoprotein E4 Allele and outcome in cerebral vascular disease. Stroke, 29: 1882-1887.
12. Miyata M, Smith JD 1996 .Apolipoprotein E allele specific antioxident activity and effects on cytotoxocity by oxidative insalts and beta amyloid peptide. Nat Genet, 14: 55-61.
13. Moysich KB, Freudenheim JL, Barker JA, Ambrose CB, Bowman ED, Schisterman EF, Vena JE, Shields PG 1999. Apo E4 gene linked to breast cancer. Brit Med J, 319: 662.
14. Moysich KB, Freudenheim JL, Barker JA, Ambrose CB, Bowman ED, Schisterman EF, Vena JE, Shields PG 2000 . Apolipoprotein E genetic polymorphism, Serum lipoproteins, and breast cancer risk. Mol Carcinog, 27: 2-9.
15. Nai-Wen Chang, Dar-Ren Chen, Chen-Ten Wu, Bradley E.Aouizerat, Fei-Na Chen, Shin-Jer Hung, Shiuan-Huei Wang, Ming-Feng Wei, and Cheng-Shyong Chang 2005. Influence of apolipoprotein E polymorphism on the risk for breast cancer and HER2/neu status in Taiwan.Breast Cancer Research and Treatment, 90: 257-261.
16. Neimi M, Corvine K, Kiviniemi H, Lukkarinen O, Kylloman AP, Sarkkinen MA, Savolainen MI, Kesaniemi YA 2000. Apolipoprotein E phenotype, Cholesterol and breast and prostrate cancer. J Epidemiol Commun Health, 54: 938.
17. Neimi M, Hakkinen T, Karttunen TJ, Eskelinen S, Kervinen K, Savollainen MJ, Lehtole J, Makela J, Yla-Herttula S, Kesanim YA 2002.Apolipoprotein E and colon cancer: Expression in normal and malignant human intestine and effects on cultured human colonic adenocarcinoma cells .Eur J.intern Med, 13(1): 37-43.
18. Neely MD, Montine TJ 2002. CSF lipoprotein and Alzheimer's disease. JNHA, 6(6): 6.
19. Nuremberg and Lahari 1991. A rapid nonenzymatic method for the preparation of HMW DNA from blood RFLP studies. Nucleic Acid research, 19: 544.
20. Peik YK, DJ Chang, CA Reardon, GE Davies, RW Mahley and JM Taylor 1989. Nucleotide sequence and structure at the human apolipoprotein E gene. Porc.Latl.Acad.Sei, USA, 82: 3445-3449.
21. Poirier J, Davignon J, Bouthillier D 1993.Apolipoprotein E polymorphism and Alzheimer's disease. Lancet, 342: 697-699.
22. Rubinsztein DC, Hanlon CS, Irving RM, Goodburnn S, Erans DGR, Kellar-Wood H, Xuereb JH, Bandmann O, Hardind AE1994 . Apo E genotype in multiple sclerosis, Parkinson disease, Schwannomas and late onset alzheimer's disease. Mol Cell Probes, 8(6): 519-525.
23. Saunders IS. Striffmatter.WJ, Schmechal D, Roses A 1993. Association of Apolipoprotein E4 with late onset familial and sporadic Alzheimer's disease. Neurology, 43:1467-1472.
24. Striffmatter WJ, Saunders AM, Schmechal D, Roses A 1993. Apolipoprotein E: High avidity binding to b-Amyloid and increased frequency of type 4 allele and late onset familial Alzheimer's disease. Proc Natl Acad Sci USA, 90:1977-1981.
25. Takatani O, Okunoto T, Kosano H 1991. Genesis of breast cancer in Japenese: A possible relationship between sex hormone binding globulin (SHBG) and serum lipid components. Breast Cancer Res Treat, 18 (Suppl 1): 527-529.
26. Teasdall G, Nicoll JAR, Murray G, Fiddes M 1977. Association of Apolipoprotein E with outcome after head injury. Lancet, 350: 1069-1071.
27. Uterrmann G 1987. Apolipoprotein E polymorphism in health and disease. Am Heart J, 113: 433-440.
28. Weisgraber KH, Rall JN and Mahlei RW 1981. Human E apolipoprotein in heterogeneity cysteine arginine interchange in the aminoacid sequence of the apo E isoform. JBiol Chem, 256: 9977-9983.
29. Zunarelli E, Nicoll JAR, Trentini GP 2000. Apolipoprotein E polymorphisms and central nervous system tumors: Correlation with cell proliferation indices and clinical outcome. Clin Neuropathol, 101(1): 1-7.